WITTE OWEN N. 4
4 · Allogene Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
WITTE OWEN N.
Director
Transactions
- Award
Common Stock
2022-06-15+22,089→ 243,271 total - Award
Stock Option (Right to Buy)
2022-06-15+35,535→ 35,535 totalExercise: $9.62Exp: 2032-06-15→ Common Stock (35,535 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly installments.